肿瘤学期刊青年编辑初审阶段对学术不端行为的甄别与防范策略  

Discrimination and Prevention Strategies of Academic Misconduct for Young Editors of Oncology Journals in Preliminary Review Stage

作　　者：吴瑕 戴丽琼[1] WU Xia;DAI Liqiong(Zhejiang Cancer Hospital,Hangzhou Institute of Medicine(HIM),Chinese Academy of Sciences,Editorial Board of Journal of Chinese Oncology,Hangzhou 310022,China)

机构地区：[1]浙江省肿瘤医院,中国科学院杭州医学研究所,《肿瘤学杂志》编辑部,浙江杭州310022

出　　处：《中国肿瘤》2023年第12期965-970,共6页China Cancer

摘　　要：当前肿瘤学期刊出版过程中学术不端行为屡禁不止且表现形式多样,青年编辑往往难以甄别,给初审工作带来困难和挑战。全文结合文献和编辑实例,总结了肿瘤学期刊初审阶段包括不实作者信息、不当署名、不实基金标注、跨语种抄袭、伪造内容与数据等方面隐性学术不端的特征和表现类型,提出应当从提升青年编辑自身编辑专业素养和加强编辑部支持与制度建设两方面来实现初审阶段对学术不端行为的甄别与防范,提高出版质量,帮助青年编辑快速成长;同时提醒作者注重学术诚信,端正学术态度,自觉抵制学术不端行为。At present,the academic misconduct in oncology journals frequently occurs despite repeated prohibition.It is difficult for young editors to discriminate and identify the academic misconduct in the preliminary review of manuscripts.Various forms of academic misconduct are seen in medical journals at the preliminary review stage,including inappropriate authorship,false and inappropriate labeling of fund project,cross-language plagiarism,fake contents and data,etc.,which suggest that in order to identified misconduct at preliminary review stage it is important for young editors to improve their professional quality and consistently obtain supports from the editorial department.At the same time,the authors should maintain academic integrity,take strict scientific attitude and consciously refuse any academic misconduct.

关 键 词：肿瘤学期刊 初审 学术不端 青年编辑 

分 类 号：R73[医药卫生—肿瘤] G232[医药卫生—临床医学]